Literature DB >> 23959984

Primary marrow-derived stromal cells: isolation and manipulation.

Aravind Ramakrishnan1, Beverly Torok-Storb, Manoj M Pillai.   

Abstract

Marrow stromal cells (MSCs) are relatively rare cells difficult to visualize in marrow biopsies or detect in aspirated marrow. Under specific conditions MSC can be expanded in vitro and the population can give rise to several mesenchymal lineages. "MSC" also refers to mesenchymal stem cells which implies that all cells in the population are multipotent. It is generally agreed that while there may be a few multipotent stem cells in an MSC population the majority are not stem cells. In either case MSCs do not produce hematopoietic cells. Although MSCs have been isolated and characterized from several tissues, bone marrow is their most common source for research and clinical use. Primary MSC populations can be derived from bone marrow mononuclear cells with relative ease, but it is important to recognize the cellular heterogeneity within a culture and how this may vary from donor to donor. In this chapter, we describe methodology to derive primary MSCs from bone marrow screens, an otherwise discarded by-product of bone marrow harvests used for clinical transplantation. We also describe some useful techniques to characterize and manipulate MSCs-both primary and immortalized cell lines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23959984      PMCID: PMC3748384          DOI: 10.1007/978-1-62703-508-8_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  50 in total

1.  STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro.

Authors:  Karina Stewart; Peter Monk; Susan Walsh; Carolyn M Jefferiss; Julie Letchford; Jon N Beresford
Journal:  Cell Tissue Res       Date:  2003-07-22       Impact factor: 5.249

Review 2.  Stem cell-stromal cell interactions.

Authors:  C Chabannon; B Torok-Storb
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

3.  The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.

Authors:  E Huang; K Nocka; D R Beier; T Y Chu; J Buck; H W Lahm; D Wellner; P Leder; P Besmer
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

4.  Identification of a ligand for the c-kit proto-oncogene.

Authors:  D E Williams; J Eisenman; A Baird; C Rauch; K Van Ness; C J March; L S Park; U Martin; D Y Mochizuki; H S Boswell
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

Review 5.  Uncertainty in the niches that maintain haematopoietic stem cells.

Authors:  Mark J Kiel; Sean J Morrison
Journal:  Nat Rev Immunol       Date:  2008-03-07       Impact factor: 53.106

6.  Genzyme backs Osiris, despite Prochymal flop.

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2009-11       Impact factor: 54.908

7.  Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration.

Authors:  Dongsu Park; Joel A Spencer; Bong Ihn Koh; Tatsuya Kobayashi; Joji Fujisaki; Thomas L Clemens; Charles P Lin; Henry M Kronenberg; David T Scadden
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

Review 8.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

9.  Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche.

Authors:  Fumio Arai; Atsushi Hirao; Masako Ohmura; Hidetaka Sato; Sahoko Matsuoka; Keiyo Takubo; Keisuke Ito; Gou Young Koh; Toshio Suda
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

View more
  12 in total

1.  Comparable osteogenic capacity of mesenchymal stem or stromal cells derived from human amnion membrane and bone marrow.

Authors:  Mehran Ghasemzadeh; Ehteramolsadat Hosseini; Mohammadhossein Ahmadi; Maedeh Kamalizad; Naser Amirizadeh
Journal:  Cytotechnology       Date:  2018-01-05       Impact factor: 2.058

2.  Expression of inflammatory cytokines in mesenchymal stem cells derived from proximal humerus fractures.

Authors:  Magda Massae Hata Viveiros; Márcio Eduardo de Melo Viveiros; Márcia Guimarães Silva; Ramon Kaneno; Natália Porfírio Avelino; Cláudia Aparecida Rainho; Silvana Artioli Schellini
Journal:  Stem Cell Investig       Date:  2022-04-12

Review 3.  Fat and bone interactions.

Authors:  Sandra Bermeo; Krishanthi Gunaratnam; Gustavo Duque
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

4.  Expression of interleukin-12 by adipose-derived mesenchymal stem cells for treatment of lung adenocarcinoma.

Authors:  Xin Li; Peng Zhang; Xiaozhi Liu; Peng Lv
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

5.  Size and dielectric properties of skeletal stem cells change critically after enrichment and expansion from human bone marrow: consequences for microfluidic cell sorting.

Authors:  Miguel Xavier; María C de Andrés; Daniel Spencer; Richard O C Oreffo; Hywel Morgan
Journal:  J R Soc Interface       Date:  2017-08       Impact factor: 4.118

Review 6.  Control of cell behaviour through nanovibrational stimulation: nanokicking.

Authors:  Shaun N Robertson; Paul Campsie; Peter G Childs; Fiona Madsen; Hannah Donnelly; Fiona L Henriquez; William G Mackay; Manuel Salmerón-Sánchez; Monica P Tsimbouri; Craig Williams; Matthew J Dalby; Stuart Reid
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2018-05-28       Impact factor: 4.226

7.  Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer.

Authors:  Ramya Lakshmi Rajendran; Sanjita Paudel; Prakash Gangadaran; Ji Min Oh; Eun Jung Oh; Chae Moon Hong; Sangkyu Lee; Ho Yun Chung; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Pharmaceutics       Date:  2021-02-10       Impact factor: 6.321

8.  Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial.

Authors:  Yuanyuan Wang; Andrew Shimmin; Peter Ghosh; Paul Marks; James Linklater; David Connell; Stephen Hall; Donna Skerrett; Silviu Itescu; Flavia M Cicuttini
Journal:  Arthritis Res Ther       Date:  2017-08-02       Impact factor: 5.156

9.  Hybrid complexes of high and low molecular weight hyaluronan delay in vitro replicative senescence of mesenchymal stromal cells: a pilot study for future therapeutic application.

Authors:  Nicola Alessio; Antonietta Stellavato; Tiziana Squillaro; Stefania Del Gaudio; Giovanni Di Bernardo; Gianfranco Peluso; Mario De Rosa; Chiara Schiraldi; Umberto Galderisi
Journal:  Aging (Albany NY)       Date:  2018-07-12       Impact factor: 5.682

Review 10.  Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee.

Authors:  Sunhee Jang; Kijun Lee; Ji Hyeon Ju
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.